Spider Venom Used To Combat Chronic Pain?
the Clinical Pain Advisor take:
Seven compounds found in spider venom have the ability to block pain signals to the brain, according to study published in the British Journal of Pharmacology.
Researchers from The University of Queensland’s Institute for Molecular Bioscience, in Australia, built a system that looked at the venoms of 206 species of spider. Of the seven compounds they identified that could block the pain signals, they discovered one that was particularly potent.
The researchers noted that this one compound had all the properties desirable for designing a medication, noting the compound's high levels of chemical, thermal, and biological stability.
Currently, medications that are targeted toward blocking pain are limited in efficacy and have documented adverse events, so finding a new approach to pain management is critical, the researchers noted.
About 15% of the adult population is affected by chronic pain affected, with an associated cost about $600 billion in the United States, the researchers noted. .
Of the seven compounds they identified that could block the pain signals, they discovered one that was particularly potent.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics